NCT01802450 Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Status UNKNOWN Phase PHASE2
NCT01797848 Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients Status WITHDRAWN Phase PHASE3
NCT01795911 Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin Status COMPLETED Phase PHASE2
NCT01793103 Brigham and Women's Rheumatoid Arthritis Sequential Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01791491 Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients Status COMPLETED Phase PHASE2
NCT01790594 Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation Status TERMINATED Phase PHASE2
NCT01783938 Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064) Status COMPLETED Phase PHASE2
NCT01780987 AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients Status COMPLETED Phase PHASE3
NCT01775631 Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma Status COMPLETED Phase PHASE1
NCT01766817 Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT01766050 Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers Status COMPLETED Phase PHASE4
NCT01763190 Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment Status COMPLETED Phase PHASE1
NCT01762462 Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT01755494 A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration Status COMPLETED Phase PHASE1
NCT01754974 Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C Status COMPLETED Phase PHASE3
NCT01752985 Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Status TERMINATED Phase PHASE2
NCT01750580 Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor Status COMPLETED Phase PHASE1
NCT01741545 Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia Status COMPLETED Phase PHASE3
NCT01740401 CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma Status TERMINATED Phase PHASE2